SUMMARY The measurement of total haemolytic complement is of diagnostic value in the rheumatic diseases. A method which is easier to perform than that of Kabat and Mayer (Experimental Immunochemistry, 2nd ed., Thomas, Springfield, Ill.) is described. A unit based on the mean value of the complement activities of normal sera is proposed to replace CH50 units. Other steps by which standardization of the assay may be improved are suggested.
The lysis of a red cell by the complement system proceeds by a series of reactions of the complement components with different sites on the cell surface. Depletion of complement components of the serum or other body fluids in diseases may be detected by measuring the overall haemolytic activity, following a method such as that of Kabat and Mayer (1961) . It is usual to express the results of such assays in terms of the 'total haemolytic complement (CH5o) units'.
The technique requires the measurement by pipette of quite large volumes of solutions, which makes the routine assay of moderate numbers of specimens tedious. Furthermore, some published observations are not in accord with the theory for the assay described by Kabat and Mayer (1961) .
In the course of developing a simpler routine technique we were able to assess the validity of their assay.
Material
Alsever's solution was prepared as described by Kabat and Mayer (1961 Kabat and Mayer (1961 (Walton and Ellis, 1958; Garratty, 1970) . In confirmation of this earlier work, our results (Table 1) indicate that a change in red cell donor alone can give rise to nearly a two-fold difference in the values of CH50. The Kent and Fife (1963) unit of complement activity is defined in a similar way. CH50 units so defined make the clinical interpretation of laboratory results unnecessarily difficult. In order to arrive at a unit more satisfactory for routine purposes, we determined the complement activities of a group of seven normal (staff) sera, and calculated the mean and the activity of one of the sera as a percentage of this mean.
Portions of this serum, stored at -170'C (Garratty, 1970) The occurrence of normal and abnormal inhibitors of complement lysis in body fluids was discussed by Gewurz and Suyehira (1976) . We have found that plotting percentage haemolysis against sample volume using the mathematical transformation of Kabat and Mayer (1961) for assay results did not always give parallel straight lines. Such parallelism is a necessary condition for an assay to be valid and accurate (Finney, 1952) . The likelihood that the human agglutinins, rheumatoid factors, and immune complexes present in some specimens were interfering was considered. A sheep was selected, the cells of which were not agglutinated by a number of human sera, including one reference anti-A serum, following a suggestion of Lachmann and co-workers (1973) . Repeated assays over two months upon a single serum gave a smaller range of values for serum volume giving 50 % lysis when blood from this sheep was used (Table 4) , compared to earlier results from random bleedings (Table 1) . Two assays done six days apart with the same sheep cells gave results which agreed well (Table 5) . Somewhat greater differences appeared in an assay in which two batches of blood from this sheep were compared (Table 6) . By choosing suitable animals as a source of cells it seems probable that better intra-and interlaboratory agreement between 'complement' assays may be achieved. Further improvement in the assay may be possible if rabbit antiserum containing little or no IgG antibody is used, so that rheumatoid factors cannot interfere. In summary, therefore, the assay described by Kabat and Mayer (1961) for measuring 'total haemolytic complement' is unsatisfactory in several respects: 1 The CH5o unit is defined in terms of cell numbers and takes no account of the large differences in sensitivity to complement lysis of cells from different sheep. 2 Reliable measurements of haemolysis at 541 nm demand good spectrophotometers. 3 An implicit assumption, which is not true, is that human body fluids show only quantitative differences in behaviour in complement assays. Even when appropriate controls and one cell source are used some specimens still have lytic characteristics different from that of a normal serum. At present the anomalies of the 'total haemolytic complement' assay are such that it can be considered semiquantitative only.
The major difficulty which appears in consequence is that of re-interpreting the published data of 'complement' levels in patients with various diseases, which give the results in the CH5o units of Kabat and Mayer (1961) or related units. Only recently has the necessity for internal serum standards for assays become apparent and, even so, assays are not rigidly standardised. The CH5o values reported, for example, by Sonozaki and Torisu (1970) in patients with either osteo-or rheumatoid arthritis, cover an unexpectedly wide range and show a considerable overlap. Our results suggest that improvements in the technique for measuring complement activity may enhance the ability of the test to discriminate between patients with different diseases.
